Skip to main content
logo
Annexin Pharmaceuticals AB (publ) (STO:ANNX)
Sweden flag Sweden · Delayed Price · Currency is SEK
12.95
-0.30 (-2.26%)
Sep 4, 2026, 12:58 PM CET

STO:ANNX Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
9414023188154137
Market Cap Growth
-48.64%-39.44%161.10%-42.68%12.35%9.62%
Enterprise Value
8810320587117130
Last Close Price
13.2519.5141.6523.4054.4154.52

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
37.075.6116.834.705.112.94
P/TBV Ratio
38.815.6417.174.795.202.97

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-2.09-1.10-1.19-1.14-1.03-1.06
Net Debt / EBITDA Ratio
0.130.760.330.490.770.94
Net Debt / FCF Ratio
0.130.740.330.490.761.10
Quick Ratio
1.085.323.153.035.058.33
Current Ratio
1.195.473.273.135.168.37
Return on Equity (ROE)
-177.52%-190.93%-308.99%-179.93%-105.95%-154.80%
Return on Assets (ROA)
-91.67%-92.27%-137.55%-86.77%-56.80%-84.72%
Return on Capital Employed (ROCE)
-1659.20%-145.60%-367.50%-234.10%-134.80%-113.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-45.43%-26.40%-21.77%-49.84%-26.41%-37.99%
FCF Yield
-43.46%-26.51%-21.76%-49.10%-26.70%-32.81%
Buyback Yield / Dilution
--46.31%-170.59%-14.23%-78.30%-33.40%